Characteristic | Kp from OHD patients (n = 29) | Kp from non-OHD patients (n = 134) | P Value |
---|---|---|---|
Hypermucoviscosity | 8 (27.6) | 42 (31.3) | 0.691 |
Capsular serotypes | |||
 K1 | 11 (37.9) | 55 (41.0) | 0.757 |
 K2 | 5 (17.2) | 26 (19.4) | 0.788 |
 K5 | 1 (3.4) | 7 (5.2) | 1.000 |
 K20 | 1 (3.4) | 2 (1.5) | 0.447 |
 non-type | 11 (37.9) | 43 (32.1) | 0.545 |
Virulence genes | |||
 aerobactin | 22 (75.9) | 117 (87.3) | 0.197 |
 rmpA | 25 (86.2) | 130 (97.0) | 0.049* |
 iroN | 4 (13.8) | 36 (26.9) | 0.138 |
 kfuBC | 17 (58.6) | 99 (73.9) | 0.100 |
 wcaG | 18 (62.1) | 94 (70.1) | 0.395 |
 ybtA | 23 (79.3) | 97 (72.4) | 0.443 |
 magA | 9 (31.0) | 65 (48.5) | 0.087 |
 fimH | 29 (100.0) | 127 (94.8) | 0.451 |
 mrkD | 29 (100.0) | 134 (100.0) | NA |
 uge | 26 (89.7) | 121 (90.3) | 1.000 |
 entB | 24 (82.8) | 120 (89.6) | 0.475 |
 ureA | 27 (93.1) | 118 (88.1) | 0.646 |
Antimicrobial resistance | |||
 Ampicillin | 29 (100.0) | 134 (100.0) | NA |
 Ampicillin/sulbactam | 7 (24.1) | 10 (7.5) | 0.020* |
 Piperacillin/tazobactam | 2 (6.9) | 0 (0.0) | 0.031* |
 Cefazolin | 6 (20.7) | 4 (3.0) | 0.001* |
 Cefotetan | 2 (6.9) | 0 (0.0) | 0.031* |
 Aztreonam | 5 (17.2) | 0 (0.0) | 0.000* |
 Ceftriaxone | 5 (17.2) | 1 (0.7) | 0.000* |
 Ceftazidime | 3 (10.3) | 0 (0.0) | 0.005* |
 Cefepime | 4 (13.8) | 0 (0.0) | 0.001* |
 Cefoperazone/sulbactam | 0 (0.0) | 0 (0.0) | NA |
 Ertapenem | 2 (6.9) | 1 (0.7) | 0.082 |
 Imipenem | 3 (10.3) | 2 (1.5) | 0.040* |
 Ciprofloxacin | 5 (17.2) | 0 (0.0) | 0.000* |
 Levofloxacin | 4 (13.8) | 0 (0.0) | 0.001* |
 Gentamicin | 1 (3.4) | 1 (0.7) | 0.325 |
 Tobramycin | 1 (3.4) | 1 (0.7) | 0.325 |
 Amikacin | 0 (0.0) | 1 (0.7) | 1.000 |
 SMZ-TMP | 4 (13.8) | 2 (1.5) | 0.008* |
 Nitrofurantoin | 13 (44.8) | 21 (15.7) | 0.000* |
MDRÂ strains | 7 (24.1) | 5 (3.7) | 0.001* |
CRKPÂ strains | 3 (10.3) | 3 (2.2) | 0.119 |
Multilocus sequence typing | |||
 ST23 | 6 (20.7) | 57 (42.5) | 0.028* |
 ST29 | 3 (10.3) | 7 (5.2) | 0.538 |
 ST65 | 2 (6.9) | 12 (9.0) | 1.000 |
 ST86 | 2 (6.9) | 8 (6.0) | 1.000 |